1 | MRNA | Moderna, Inc. | 2.74% |
2 | REGN | Regeneron Pharmaceuticals, Inc. | 2.55% |
3 | EXEL | Exelixis, Inc. | 2.55% |
4 | NBIX | Neurocrine Biosciences, Inc. | 2.52% |
5 | UTHR | United Therapeutics Corporation | 2.49% |
6 | HALO | Halozyme Therapeutics, Inc. | 2.48% |
7 | ALNY | Alnylam Pharmaceuticals, Inc. | 2.45% |
8 | VRTX | Vertex Pharmaceuticals Incorporated | 2.42% |
9 | INSM | Insmed Incorporated | 2.41% |
10 | GILD | Gilead Sciences, Inc. | 2.38% |
11 | BMRN | BioMarin Pharmaceutical Inc. | 2.36% |
12 | AMGN | Amgen Inc. | 2.36% |
13 | INCY | Incyte Corporation | 2.35% |
14 | BIIB | Biogen Inc. | 2.32% |
15 | ABBV | AbbVie Inc. | 2.30% |
16 | BBIO | BridgeBio Pharma, Inc. | 2.26% |
17 | EXAS | Exact Sciences Corporation | 2.26% |
18 | NTRA | Natera, Inc. | 2.20% |
19 | BPMC | Blueprint Medicines Corporation | 1.91% |
20 | MDGL | Madrigal Pharmaceuticals, Inc. | 1.89% |
21 | TGTX | TG Therapeutics, Inc. | 1.77% |
22 | ROIV | Roivant Sciences Ltd. | 1.66% |
23 | CYTK | Cytokinetics, Incorporated | 1.58% |
24 | CRSP | CRISPR Therapeutics AG | 1.55% |
25 | IONS | Ionis Pharmaceuticals, Inc. | 1.48% |
View XBI holdings |